Zacks

Zacks Small Cap Research – LOBO: Busy Quarter on the Product/Distribution/Capital Fronts; Earnings Power Set to Ramp Up – Go Health Pro

by

By Michael Kim NASDAQ:LOBO LOBO EV Technologies (NASDAQ:LOBO) designs and manufactures e-Bicycles, e-Mopeds, motorcycles, e-Tricycles, autonomous robotic lawn mowers, and electric off-highway four-wheeled shuttles (golf carts and scooters for elderly and disabled persons) for distribution through a broad-based dealership network in China, Southeast Asia, Latin America, Europe, and the United States. Following the release of … Read more

Zacks Small Cap Research – PERF: Perfect Corp Closes Acquisition of Wannaby – Go Health Pro

by
Zacks Small Cap Research – PERF: Perfect Corp Closes Acquisition of Wannaby – Go Health Pro

By Lisa Thompson NYSE:PERF READ THE FULL PERF RESEARCH REPORT On Wednesday, Perfect Corp. (NYSE:PERF) closed its acquisition of Wannaby Inc. Wannaby, known as WANNA on Crunchbase, is the provider of a try-on technology platform for the fashion industry. It is located in Redwood City, California, and Lithuania and has approximately 24 employees. The company … Read more

Zacks Small Cap Research – TELO Continues to Impress – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere caps. Previously reported preclinical tests have shown evidence that Telomir-1, the company’s primary therapy, can lengthen telomeres and initial animal testing illustrates the potential impact. … Read more

Zacks Small Cap Research – CTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT On January 3, 2025, CytoSorbents (NASDAQ:CTSO) reported strong preliminary 4th quarter and full year 2024 financial results which exceeded our expectations. 4th quarter product revenue (excluding grant income) is estimated to be in the range of $9.0-$9.2 million, which is approximately 22% to 25% … Read more

Zacks Small Cap Research – AIRE: Positioning to Benefit From Expected Shift in Real Estate Transactions Model, Initiating Coverage – Go Health Pro

by
Zacks Small Cap Research – AIRE: Positioning to Benefit From Expected Shift in Real Estate Transactions Model, Initiating Coverage – Go Health Pro

By M. Marin NASDAQ:AIRE READ THE FULL AIRE RESEARCH REPORT Positioning commission free real estate technology platform to benefit from expected dramatic shift within real estate sector reAlpha Tech Corp. (NASDAQ:AIRE) is a real estate technology company that is developing an end-to-end commission-free homebuying platform. The reAlpha platform leverages artificial intelligence (AI) technologies in the … Read more

x